Bitfount

Learn more about Bitfount’s AI-based patient pre-screening solution: bitfount.com/solutions/bitf… Read the full paper here: ophthalmologyscience.org/article/S2666-…

The results showed that deploying deep-learning AI models on data directly within hospital systems helped identify ~100x more eligible patients than would normally be found via the current system of manual image analyses and health record searches.

AI-based patient pre-screening finds 64% more eligible patients than EHR search.

At Bitfount, we’re helping sponsors and researchers find eligible participants faster, streamline pre-screening, with the use of Bitfount's on-premise AI platform. Learn more about Bitfount's work:bitfount.com/solutions/bitf…

The week was full of innovation, collaboration, and meaningful conversations around the future of ophthalmology. The prominence of AI being featured across the conference is proof that ophthalmology is embracing smarter ways to accelerate research and improve patient outcomes

Bitfount at ARVO 2025. A huge thank you to everyone who stopped by the Bitfount booth at this year’s ARVO in Salt Lake City!

Meet our team to explore how Bitfount's on-premise AI platform specialises in accelerating ophthalmic research and clinical trials by enabling advanced analytics for ophthalmic imaging and EHR data, without clinics and hospitals ever having to share their data.

Bitfount is coming to the ARVO 2025 annual meeting in Salt Lake City, Utah, next month from 4-7th of May 2025. 📍Booth 2036

Explore how Bitfount is accelerating recruitment for clinical trials using AI: bitfount.com/solutions/bitf…

Elaine’s talk was a powerful reminder that every dataset we analyse and every model we build ultimately impacts someone’s quality of life. Elaine Manna’s wing walk for charity: moorfieldseyecharity.org.uk/impact-stories…

Last month, Bitfount had the absolute privilege of hosting Elaine Manna (@MannaElaine), a truly fearless and inspiring lady who graciously shared her personal journey living with age-related macular degeneration (AMD).

Meet our leadership team to explore how Bitfount's on-prem AI platform accelerates clinical research and de-risks trials by enabling advanced analytics for medical imaging and EHR data - without clinics and hospitals ever having to share their data.

Bitfount is coming to the SCOPE US in Orlando, Florida, next week from the 3rd to the 6th of February 2025. 📍Booth 724

Join us as Matt Seigel, our Head of Engineering, takes the stage to explore how AI is transforming ophthalmic trials and collaborative research. Matt will share insights into how federated data science and AI enable breakthroughs while ensuring data privacy remains paramount.

Bitfount is coming to the prestigious FLORetina Congress in Florence from December 5-8, 2024, at the historic Fortezza da Basso. This global event brings together leaders in vitreoretinal research and innovation, and we’re honoured to be part of it! 📍Booth no.2